Evaluation of an African Green Monkey Model of Transient Ischemia

Completed
4809Surgical Research – Leading the Way to Improve Patient Outcomes

Date: Wednesday, October 11, 2023
Time: 11:00 am CT
Duration: 30 Minutes
Room: Cumberland Ballroom, Salon ABCD

Speaker – Kimicia Isaac, St. Kitts
Biomedical Research Foundation / Virscio, Inc.

 

The NIH estimates 800,000 Americans suffer strokes yearly, with significant mortality, long-term disability, and substantial unmet medical need. The lack of translation from small animal models to clinical efficacy has slowed therapeutic development. Nonhuman primates (NHP) share anatomy and physiology with humans important to the clinical pathophysiology of stroke and truly predictive preclinical modeling. An model of transient ischemia is described in adult male African green monkeys (Chlorocebus sabaeus) that promises to enable more robust evaluation of stroke therapeutics.

Methods:

11 monkeys received a 180 min occlusion of the left M3 branch of the middle cerebral artery (MCA). Ketamine (8 mg/kg, IM) sedation was followed by isoflurane anesthesia (2-3% to effect) with ventilation. Body temperature, heart and respiratory rate, ECG, SpO2 , CO2 ,were monitored. After left temporal craniotomy, the M3 was isolated 5mm deep in the Sylvian cistern and an aneurism clip placed. For 2 controls, the M3 was isolated, but not clipped. After 180 min, the clip was removed, and reperfusion was visually verified. The craniotomy was filled with gelfoam and the incision closed in layers. Meloxicam (0.20 mg/kg SC) and buprenorphine (0.02 mg/kg IM) BID were administered for 3 days. 9 vehicle control and 2 untreated controls are reported.

Results: 

Infarcts were visualized in vivo on Days 1 and 3 on a Philips 1.5T MR using T1 FLAIR MRI sequences, as well as post mortem following Day 3 necropsies with H&E and Nissl staining. Infarct volumes were quantified with hand-drawn ROIs (MRI) and AI-assisted volume estimation of H&E and Nissl staining. The MCAO M3 occlusion was well tolerated with 10 NHPs surviving to the scheduled Day 3 necropsy. Seizures on Day 2 required euthanasia in 1 animal. Neurologic exams detected mild to moderate contralateral weakness in 8 animals. Infarcts were quantifiable with MRI, H&E and Nissl stains. As expected, MRI Day 3 infarct volumes were larger than Day 1 MRI infarct volumes (t=3.762, df=9, P=0.0045, Figure 1 showing a 39% increase on Day 3).

Conclusion: 

The induction of a moderate infarct results in reduced mortality compared to larger infarcts. The NHPs were able to care for themselves without additional husbandry, reducing their discomfort. This model has been used to date in two efficacy studies of novel therapeutics with mortality of 1 in 41 total NHPs (including test-article treated NHPs, not shown). This model will aid development of therapeutics for the enormous unmet medical need in stroke.

 

Additional Authors: E. Nisbett, V. Chaseau, R. Bouffard, G. Jalalahmadi, D. Allen, M. Weed

This is an archived event. Please log in with your member account to access these resources.

Share this event

Similar Events Happening

Morning Wet Lab – Vanderbilt University

Morning Wet Lab – Vanderbilt University

Date: Tuesday, October 10, 2023
Time: 8:00 am
Basic swine laparoscopy and endovascular interventions paired with an introduction to stereotaxic, intrathecal surgery, and vascular catheterization in the rat
Automated Blood Sampling in a Telemetry Cardiovascular Dog Colony

Automated Blood Sampling in a Telemetry Cardiovascular Dog Colony

Date: Wednesday, October 11, 2023
Time: 10:30 am
Speaker – Amanda Wilsey Abbvie   Implementation of Automated Blood Sampling (ABS) allows for uninterrupted cardiovascular data collection with simultaneous blood collection throughout a telemetry dog preclinical study. This reduction shortens study timelines, minimizes CV data artifacts, and considerably reduces compound synthesis and the associated costs. Methods: A colony of telemetry instrumented male beagle dogs were implanted and maintained in-house for non-GLP preclinical cardiovascular safety studies. Evaluation of the ABS telemetry dog cardiovascular model; highlighting the benefits and downfalls of the last seven years since implementing Automated Blood Sampling. Results:  Since 2016, telemetry dogs implanted with transmitters and vascular access ports […]
Evaluation of an African Green Monkey Model of Transient Ischemia

Evaluation of an African Green Monkey Model of Transient Ischemia

Date: Wednesday, October 11, 2023
Time: 11:00 am
Speaker – Kimicia Isaac, St. Kitts Biomedical Research Foundation / Virscio, Inc.   The NIH estimates 800,000 Americans suffer strokes yearly, with significant mortality, long-term disability, and substantial unmet medical need. The lack of translation from small animal models to clinical efficacy has slowed therapeutic development. Nonhuman primates (NHP) share anatomy and physiology with humans important to the clinical pathophysiology of stroke and truly predictive preclinical modeling. An model of transient ischemia is described in adult male African green monkeys (Chlorocebus sabaeus) that promises to enable more robust evaluation of stroke therapeutics. Methods: 11 monkeys received a 180 min occlusion of […]
Practical Approach to Pain Management for Nonhuman Primates: Enhancing Welfare and Research Outcomes

Practical Approach to Pain Management for Nonhuman Primates: Enhancing Welfare and Research Outcomes

Date: Wednesday, October 11, 2023
Time: 1:00 pm
Speaker – Jan Bernal Amgen   Pain management is a critical component of responsible animal research and care, particularly in the context of nonhuman primates (NHPs) utilized in biomedical and behavioral studies. This presentation aims to provide a comprehensive overview of practical pain management strategies for NHPs, with a focus on enhancing their welfare while optimizing research outcomes. The presentation will begin by defining pain and classifications of pain. It will emphasize the pain pathways and the multimodal approaches effective at each of the pain pathways, encompassing a wide range of medication and procedural options to modulate pain.  Attendees will gain […]
The Vital Role of Capnography in Surgical Research: Enhancing Patient Care and Surgical Outcomes

The Vital Role of Capnography in Surgical Research: Enhancing Patient Care and Surgical Outcomes

Date: Wednesday, October 11, 2023
Time: 1:30 pm
Speakers: Jan Bernal Amgen Amy Martunas Vertex   Capnography has emerged as an indispensable tool in veterinary medicine, revolutionizing the way we monitor and manage patients during various surgical scenarios. This presentation is dedicated to shedding light on the fundamental principles, practical applications, and clinical benefits of capnography in veterinary practice. The presentation will commence by introducing the basic principles of capnography, elucidating the physiological underpinnings of carbon dioxide (CO2) measurement, and its significance in assessing both ventilatory and circulatory aspects of patient health. Attendees will gain insights into the mechanics of capnography, including the technology behind mainstream and side stream […]